Andrew Sung
Andrew Sung is the Chief Executive Officer of BiomiXin Co., Ltd., where he leads the company’s mission to develop and commercialize sustainable biotechnology solutions in animal health, nutrition, and agricultural innovation.
A science-driven business leader, Andrew’s career spans biotechnology, agriculture, international trade, and venture development. He combines a strong scientific background with strategic and commercial expertise, positioning himself at the intersection of research, innovation, and global market expansion. His work is deeply focused on advancing probiotic and algae-based solutions designed to address pressing global challenges such as food security and micronutrient deficiencies, often referred to as “hidden hunger.”
In addition to his leadership at BiomiXin, Andrew is the Founder and Chief Executive Officer of InnoMED, a biotechnology company dedicated to dietary supplements and wound-healing products, where he has successfully bridged scientific research with consumer health applications. He is also the Founder and Chief Executive Officer of BioHealth Solutions, an international trading company specializing in feed materials and agricultural commodities, reflecting his expertise in navigating cross-border trade and ensuring the efficient distribution of agricultural resources worldwide.
His entrepreneurial reach extends further into diverse ventures and investments. Andrew has been strategically involved in water purification technologies, contributing to innovations that address global clean water challenges. He has gained exposure to medical technology, particularly in AI-driven healthcare applications, and has participated in the food and beverage (F&B) sector, focusing on brand development and supply chain optimization. These experiences highlight his versatility as a leader who can adapt across industries while maintaining a strong focus on sustainability and innovation.
Andrew’s professional expertise encompasses biotechnology and agricultural innovation, probiotic and algae research and development, international trade and cross-border market expansion, as well as venture development and multi-sector investment strategies. His ability to integrate scientific knowledge with business acumen has allowed him to create impactful ventures that contribute to both human and animal health, while also addressing global sustainability concerns.
Academically, Andrew holds a Bachelor of Science in Chemistry from National Cheng Kung University, Taiwan, and a Master of Science in International Business & Management from the Bradford University School of Management, United Kingdom. This combination of scientific and managerial training has equipped him with the tools to lead complex organizations, drive innovation, and expand businesses across international markets.
Altogether, Andrew Sung exemplifies the modern science-business leader: a professional who bridges rigorous scientific inquiry with entrepreneurial vision. His career demonstrates a commitment to solving pressing global challenges through biotechnology, sustainable agriculture, and international collaboration. Whether through his leadership at BiomiXin, his ventures in InnoMED and BioHealth Solutions, or his investments in emerging technologies, Andrew continues to drive innovation that impacts health, nutrition, and sustainability worldwide.
